ArticleCureus2025
Blink and You'll Miss It: Diagnostic Pitfalls in a Case of Missed Ocular Myasthenia Gravis in the Emergency Department.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular myasthenia gravis (MG), a subtype of MG limited to the eyelids and extraocular muscles, is diagnostically challenging in the emergency department (ED). In the absence of generalized weakness, subtle symptoms such as ptosis and diplopia are more easily overlooked or misattributed to stroke or other neurologic pathologies. We present a case of a 69-year-old male whose diagnosis of ocular MG was delayed due to limited neurologic examination, underuse of simple bedside tools, and incidental imaging findings that initially suggested alternative endocrine pathology. Despite classic signs, including fatigable ptosis and diplopia, treatment with pyridostigmine was not initiated until 31 hours after ED arrival, at which point the patient experienced near-complete resolution of ocular symptoms within one hour. This case highlights the importance of maintaining clinical suspicion for MG in cranial nerve presentations. Incorporating accessible bedside tests, such as the ice pack test or acetylcholinesterase inhibitor trial, can expedite diagnosis and treatment in the ED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.